TMPRSS2-ERG Fusion Heterogeneity in Multifocal Prostate Cancer: Clinical and Biologic Implications

Tomlins, 2005, Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer, Science, 310, 644, 10.1126/science.1117679

Mehra, 2007, Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer, Mod Pathol, 20, 538, 10.1038/modpathol.3800769

Perner, 2006, TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer, Cancer Res, 66, 8337, 10.1158/0008-5472.CAN-06-1482

Perner, 2007, TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion, Am J Surg Pathol, 31, 882, 10.1097/01.pas.0000213424.38503.aa

Demichelis, 2007, TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort, Oncogene, 26, 4596, 10.1038/sj.onc.1210237

Laxman, 2006, Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer, Neoplasia, 8, 885, 10.1593/neo.06625

Greene, 1991, A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate, J Urol, 146, 1069, 10.1016/S0022-5347(17)38003-5

Cheng, 1998, Evidence of independent origin of multiple tumors from patients with prostate cancer, J Natl Cancer Inst, 90, 233, 10.1093/jnci/90.3.233

Arora, 2004, Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate, Cancer, 100, 2362, 10.1002/cncr.20243

Qian, 1995, Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization, Cancer Res, 55, 5408

Sakr, 1994, Allelic loss in locally metastatic, multisampled prostate cancer, Cancer Res, 54, 3273

Tomlins, 2007, Integrative molecular concept modeling of prostate cancer progression, Nat Genet, 39, 41, 10.1038/ng1935

Hollenbeck, 2000, Whole mounted radical prostatectomy specimens do not increase detection of adverse pathological features, J Urol, 164, 1583, 10.1016/S0022-5347(05)67033-4

Wang, 2006, Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer, Cancer Res, 66, 8347, 10.1158/0008-5472.CAN-06-1966